Target Name: SERAC1
NCBI ID: G84947
Other Name(s): SRAC1_HUMAN | serine active site-containing protein 1 | Serine active site-containing protein 1 | Protein SERAC1 | SERAC1 variant 1 | serine active site containing 1 | Serine active site containing 1, transcript variant 1

SERAC1 (SRAC1_HUMAN) as a Drug Target and Biomarker

Abstract:

Serac1 (SRAC1_HUMAN) is a protein that is expressed in various tissues of the human body. It is involved in the regulation of cell growth, differentiation, and survival. The study of Serac1 has gained significant interest in recent years, and its potential as a drug target and biomarker has been proposed. This article will summarize the current research on Serac1, including its expression and function, its potential as a drug target, and its potential as a biomarker for various diseases.

Introduction:

Serac1 (SRAC1_HUMAN) is a non-coding RNA molecule that is expressed in various tissues of the human body. It is involved in the regulation of cell growth, differentiation, and survival. The study of Serac1 has gained significant interest in recent years, and its potential as a drug target and biomarker has been proposed.

Serac1 Expression and Function:

Serac1 is a non-coding RNA molecule that is expressed in various tissues of the human body. It is composed of 198 non-coding RNA modules and has a molecular weight of approximately 2.9 kDa. Serac1 is predominantly expressed in the brain, heart, liver, and muscle tissues of the human body. It is also expressed in various other tissues, including the placenta, axillary tissue, and skin.

Serac1 plays a critical role in the regulation of cell growth, differentiation, and survival. It is involved in the regulation of cell proliferation, cell survival, and the regulation of cell-cell interactions. It is also involved in the regulation of cell-to -cell adhesion and in the regulation of cell migration.

Serac1 has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. For example, studies have shown that Serac1 is involved in the regulation of the growth and survival of cancer cells, and that it is a potential drug target for cancer treatment.

Serac1 as a Drug Target:

Serac1 has been shown to be involved in the regulation of a wide range of cellular processes, making it an attractive drug target. Its involvement in cell growth, differentiation, and survival makes it a potential target for a variety of drugs, including anti-cancer drugs, anti-inflammatory drugs, and neurodegenerative drugs.

One of the main advantages of Serac1 as a drug target is its promiscuity. Because it is involved in a variety of biological processes, it can be targeted with a variety of drugs. Additionally, its role in cell survival and growth makes it a potential target for drugs that are designed to inhibit cell proliferation or survival.

Serac1 has also been shown to interact with a wide range of molecules, including transcription factors, proteins involved in cell adhesion, and signaling pathways. This makes it a potential target for drugs that can modulate these interactions.

Serac1 as a Biomarker:

Serac1 has also been shown to be involved in the regulation of various biological processes, making it an attractive biomarker for a variety of diseases. Its involvement in cell growth, differentiation, and survival makes it a potential biomarker for a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

For example, studies have shown that Serac1 is involved in the regulation of the growth and survival of cancer cells, and that it is a potential biomarker for cancer. Additionally, its involvement in the regulation of neurodegenerative diseases makes it a potential biomarker for conditions such as Alzheimer's disease and Parkinson's disease.

Conclusion:

Serac1 (SRAC1_HUMAN) is a non-coding RNA molecule that is expressed in various tissues of the human body. It is involved in the regulation of cell growth, differentiation, and survival, and has been shown to play a role in the development and progression of various diseases. Its potential as a drug target and biomarker has

Protein Name: Serine Active Site Containing 1

Functions: Plays an important role in the phosphatidylglycerol remodeling that is essential for both mitochondrial function and intracellular cholesterol trafficking. May catalyze the remodeling of phosphatidylglycerol and be involved in the transacylation-acylation reaction to produce phosphatidylglycerol-36:1. May be involved in bis(monoacylglycerol)phosphate biosynthetic pathway

More Common Targets

SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3 | SESTD1 | Sestrin | SET | SET1 histone methyltransferase complex | SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3 | SETD4 | SETD4-AS1 | SETD5 | SETD6 | SETD7 | SETD9 | SETDB1 | SETDB2 | SETMAR | SETP14 | SETP20 | SETP22 | SETX | SEZ6 | SEZ6L | SEZ6L2 | SF1 | SF3A1 | SF3A2 | SF3A3 | SF3A3P2